Main > NEPHROLOGY > Diabetic Nephropathy > Treatment > Bardoxolone Me (AIM) > Co.: USA. R. Phase III

---

Co.: USA. R. Phase III's subsections
Antioxidant Inflammation Modulator
Chronic Kidney Disease+Diabetes
Company
Licensee (Ex JP; Asia; USA):
Licensee (JP; Asia):
Web-Site
Web-Site (PR>2011. 06.24.2011)

Co.: USA. R. Phase III's products
This section has no products